Lazard Asset Management
KYNB

Lazard Asset Management’s Kyntra Bio KYNB Stock Holding History

Lazard Asset Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-165
Closed -$3K – 2320
2024
Q2 		$3K Buy
+165
New +$5.1K ﹤0.01% 2084
2023
Q2 		– Sell
-113
Closed -$52K – 2371
2023
Q1 		$52K Buy
+113
New +$59.8K ﹤0.01% 1775
2022
Q3 		– Sell
-225
Closed -$59K – 2393
2022
Q2 		$59K Buy
+225
New +$57.5K ﹤0.01% 1738
2022
Q1 		– Sell
-207
Closed -$73K – 2387
2021
Q4 		$73K Sell
207
-1,675
-89% -$522K ﹤0.01% 1565
2021
Q3 		$480K Buy
+1,882
New +$667K ﹤0.01% 1182
2021
Q2 		– Sell
-70
Closed -$60K – 1994
2021
Q1 		$60K Buy
+70
New +$74.5K ﹤0.01% 1362
2020
Q3 		– Sell
-88
Closed -$89K – 1648
2020
Q2 		$89K Buy
+88
New +$81.7K ﹤0.01% 1048
2020
Q1 		– Sell
-34
Closed -$36K – 1626
2019
Q4 		$36K Buy
34
+14
+70% +$14.3K ﹤0.01% 1124
2019
Q3 		$18K Buy
+20
New +$22K ﹤0.01% 1099
2018
Q1 		– Sell
-356
Closed -$421K – 1071
2017
Q4 		$421K Buy
+356
New +$446K ﹤0.01% 790
2015
Q3 		– Sell
-7,172
Closed -$4.21M – 1105
2015
Q2 		$4.21M Buy
7,172
+188
+3% +$109K 0.01% 546
2015
Q1 		$5.48M Buy
6,984
+47
+0.7% +$36.4K 0.01% 517
2014
Q4 		$4.74M Buy
+6,937
New +$4.46M 0.01% 550

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GC
GFG Capital Miami, Florida $363M AUM 45.53% 1-Year Est. Return

Lazard Asset Management's KYNB Position: Q3 2024 in Review

Lazard Asset Management sold out of Kyntra Bio (KYNB) in Q3 2024, closing a stake of 165 shares — an estimated $3K sold.

Lazard Asset Management first reported a position in KYNB in Q4 2014 and held it in 13 quarters. The position peaked at $5.48M in Q1 2015. 70 funds tracked by Wall St. Rank hold KYNB as of Q3 2024.

  • Lazard Asset Management reported no remaining Kyntra Bio position as of Q3 2024 after selling out during the quarter.
  • Lazard Asset Management sold 165 Kyntra Bio shares in Q3 2024, an estimated $3K.
  • Lazard Asset Management first reported a position in Kyntra Bio in Q4 2014 and held it in 13 quarters.
  • Lazard Asset Management's Kyntra Bio position peaked at $5.48M in Q1 2015.
  • 70 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2024.

Based on Lazard Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.